Sotorasib: A Targeted Breakthrough in KRAS G12C- Mutated Non-Small Cell Lung Cancer. (2026). International Journal of Research in Pharmaceutical Sciences and Technology, 9(3). https://doi.org/10.33974/7tt6d117